Amsterdam Public Health
-
Adalimumab serum concentration to choose a subsequent biological DMARD in patients with rheumatoid arthritis (ADDORA-switch): results of a blinded randomised test-treatment trial
Wientjes, M. H. M., Atiqi, S., Wolbink, G. J., Nurmohamed, M. T., Boers, M., Hooijberg, F., Rispens, T., de Vries, A., van Vollenhoven, R. F., Ramiro, S., van Herwaarden, N., van den Bemt, B. J. F. & den Broeder, A. A., Aug 2025, In: Annals of the rheumatic diseases. 84, 8, p. 1293-1300 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Pharmacokinetic Model-Informed Precision Dosing of Natalizumab in Multiple Sclerosis
van den Berg, S. P. H., Toorop, A. A., Hooijberg, F., Wolbink, G., Voelkner, N. M. F., Gelissen, L. M. Y., Killestein, J., van Kempen, Z. L. E., Dorlo, T. P. C. & Rispens, T., Jun 2025, In: CPT: Pharmacometrics and Systems Pharmacology. 14, 6, p. 1032-1041 10 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Population Pharmacokinetics of Adalimumab in Juvenile Idiopathic Arthritis Patients: A Retrospective Cohort Study Using Clinical Care Data
Nassar-Sheikh Rashid, A., Hooijberg, F., Bergkamp, S. C., Gruppen, M. P., Kuijpers, T. W., Nurmohamed, M., Rispens, T., Wolbink, G., van den Berg, J. M., Schonenberg-Meinema, D. & Mathôt, R. A. A., Jul 2024, In: Paediatric drugs. 26, 4, p. 441-450 10 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications